What is the main business of Mitocell?

The main business activity of Mitocell focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 11, 2023.

Where is the headquarters located?

The headquarters is located at: 864, 32-444 Głogoczów.

Who is on the management board?

The management board consists of: Agnieszka Anna Kawczyńska Dróżdż (Member of the Management Board) and Michał Łukasz Dróżdż (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of USD 98,098 in 2024, which is an increase of 376.7% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of USD 71,747, meaning the company increased its profit by 501.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under materials and energy. This category amounted to USD 10,649 in 2024, representing 55% of all operating expenses.

Mitocellsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-07-11

Share capital

5,000.00 PLN

Average employment (people)

25 (2025)

Registered address

864, 32-444 Głogoczów, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 3 financial statements was filed late (for 2025, 49 days late).

202502/09/2026
202415/07/2025
202329/06/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Research and experimental development on biotechnology151 / 386

Top 39%

Division · Scientific research and development806 / 1,953

Top 41%

Sector · Professional, scientific and technical activities16,490 / 39,215

Top 42%

City · Głogoczów25 / 38

Top 66%

Voivodeship · Małopolskie17,183 / 27,827

Top 62%

Country · Poland186,274 / 297,935

Top 63%

Results vs industry

Revenue

This companyUSD 124.34kMedianUSD 55.24kAverageUSD 2.70m

Net profit

This companyUSD 80.16kMedianUSD -1.27kAverageUSD -92.18k

Operating costs

This companyUSD 36.41kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 170.79kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Agnieszka Kawczyńska Dróżdż – Management Board Member

Michał Łukasz Dróżdż – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Michał Łukasz Dróżdżage 49	25	$675.31	50%
Agnieszka Anna Kawczyńska Dróżdżage 48	25	$675.31	50%

Agnieszka Anna Kawczyńska Dróżdż and Michał Łukasz Dróżdż hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2023-07-24.

mBank
56 1140 2004 0000 3102 8389 9876

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
AI Corelabsp. z o.o.	$128,365.55	aicorelab.com
Relvosp. z o.o.	$120,693.26	relvo.pl
Microblicsp. z o.o.	$122,383.50	microblic.pl
Biodecsp. z o.o.	$115,508.63	biodec.pl
IntelliseqS.A.	$111,419.60	intelliseq.pl
ModicaP.S.A.	$103,400.72	modica.bio
Microbe Plussp. z o.o.	$104,197.26	microbe-plus.com
WPD Pharmaceuticalssp. z o.o.	$90,822.78	wpdpharmaceuticals.com
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.	$54,163.54	geneza.eu